Does BUPROPION HYDROBROMIDE Cause Off label use? 32 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Off label use have been filed in association with BUPROPION HYDROBROMIDE (Aplenzin). This represents 13.6% of all adverse event reports for BUPROPION HYDROBROMIDE.
32
Reports of Off label use with BUPROPION HYDROBROMIDE
13.6%
of all BUPROPION HYDROBROMIDE reports
10
Deaths
7
Hospitalizations
How Dangerous Is Off label use From BUPROPION HYDROBROMIDE?
Of the 32 reports, 10 (31.3%) resulted in death, 7 (21.9%) required hospitalization, and 1 (3.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUPROPION HYDROBROMIDE. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does BUPROPION HYDROBROMIDE Cause?
Headache (82)
Asthma (68)
Gastrooesophageal reflux disease (64)
Therapeutic product effect incomplete (61)
Wheezing (59)
Hypertension (55)
Fibromyalgia (46)
Blood test abnormal (45)
Burning sensation (45)
Cardiac disorder (45)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which BUPROPION HYDROBROMIDE Alternatives Have Lower Off label use Risk?
BUPROPION HYDROBROMIDE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE
BUPROPION HYDROBROMIDE vs BUPROPION\NALTREXONE
BUPROPION HYDROBROMIDE vs BUROSUMAB
BUPROPION HYDROBROMIDE vs BUROSUMAB-TWZA
BUPROPION HYDROBROMIDE vs BUSPIRONE